The Chart of the Day belongs to Celladon (NASDAQ:CLDN). I found the stock by sorting the All Time High list for the stocks hitting the most frequent highs in the last month, then used the Flipchart feature to review the charts. Since the Trend Spotter signaled a buy on 10/27 the stock gained 81.38%.
Celladon Corporation is a biotechnology company. It focuses on developing treatments for heart failure, diabete and neurodegenerative diseases. The company's lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to correct the Sarco/endoplasmic reticulum Ca2+-ATPase 2a enzyme deficiency in heart failure patients. Its MYDICAR product is developed to treat patients with systolic heart failure, diastolic heart failure and advanced heart failure as well as to treat pulmonary arterial hypertension and arteriovenous fistula maturation failure.
Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
Fundamental factors:
This stock has had a very steep run up recently if you have it be prepared to skim off some profits. If you're not in it yet, I think you missed the boat.
